IMBiologics financial statements
KRX:493280 · KOSDAQ · Healthcare · sector #23₩13,160-4.64%Oct 30 close
IMBiologics's 2025 annual results accompany close-price data dated 2026-10-30. 2025 revenue was KRW 11.62B. 2025 operating profit was KRW 297.7M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy